These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35489667)

  • 1. In situ gelling nanosuspension as an advanced platform for fluticasone propionate nasal delivery.
    Nižić Nodilo L; Perkušić M; Ugrina I; Špoljarić D; Jakobušić Brala C; Amidžić Klarić D; Lovrić J; Saršon V; Safundžić Kučuk M; Zadravec D; Kalogjera L; Pepić I; Hafner A
    Eur J Pharm Biopharm; 2022 Jun; 175():27-42. PubMed ID: 35489667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovative sprayable in situ gelling fluticasone suspension: Development and optimization of nasal deposition.
    Nižić L; Ugrina I; Špoljarić D; Saršon V; Kučuk MS; Pepić I; Hafner A
    Int J Pharm; 2019 May; 563():445-456. PubMed ID: 30965121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of Tamsulosin Hydrochloride-Loaded Mucoadhesive In Situ Gelling Polymeric Formulation for Nasal Delivery in Geriatrics.
    Rana SJ; Zafar S; Shahzad A; Basit M; Mudassir J; Akhlaq M; Chohan TA; Arshad MS
    AAPS PharmSciTech; 2023 Nov; 24(8):242. PubMed ID: 38017208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanosuspension based in situ gelling nasal spray of carvedilol: development, in vitro and in vivo characterization.
    Saindane NS; Pagar KP; Vavia PR
    AAPS PharmSciTech; 2013 Mar; 14(1):189-99. PubMed ID: 23255198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan-Based Thermogelling System for Nose-to-Brain Donepezil Delivery: Optimising Formulation Properties and Nasal Deposition Profile.
    Perkušić M; Nižić Nodilo L; Ugrina I; Špoljarić D; Jakobušić Brala C; Pepić I; Lovrić J; Safundžić Kučuk M; Trenkel M; Scherließ R; Zadravec D; Kalogjera L; Hafner A
    Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery to the brain: In situ gelling formulation enhances carbamazepine diffusion through nasal mucosa models with mucin.
    Corazza E; di Cagno MP; Bauer-Brandl A; Abruzzo A; Cerchiara T; Bigucci F; Luppi B
    Eur J Pharm Sci; 2022 Dec; 179():106294. PubMed ID: 36116696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation.
    Alshweiat A; Csóka I; Tömösi F; Janáky T; Kovács A; Gáspár R; Sztojkov-Ivanov A; Ducza E; Márki Á; Szabó-Révész P; Ambrus R
    Int J Pharm; 2020 Apr; 579():119166. PubMed ID: 32084574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ hydrogel containing diazepam-loaded nanostructured lipid carriers (DZP-NLC) for nose-to-brain delivery: development, characterization and deposition studies in a 3D-printed human nasal cavity model.
    Pina Costa C; Nižić Nodilo L; Silva R; Martins E; Zadravec D; Kalogjera L; Nuno Moreira J; Manuel Sousa Lobo J; Hafner A; Catarina Silva A
    Int J Pharm; 2023 Sep; 644():123345. PubMed ID: 37619806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery.
    Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H
    Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deposition of intranasal glucocorticoids--preliminary study.
    Rapiejko P; Sosnowski TR; Sova J; Jurkiewicz D
    Otolaryngol Pol; 2015; 69(6):30-8. PubMed ID: 26860605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailoring functional spray-dried powder platform for efficient donepezil nose-to-brain delivery.
    Perkušić M; Nižić Nodilo L; Ugrina I; Špoljarić D; Jakobušić Brala C; Pepić I; Lovrić J; Matijašić G; Gretić M; Zadravec D; Kalogjera L; Hafner A
    Int J Pharm; 2022 Aug; 624():122038. PubMed ID: 35870666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical properties of fluticasone propionate nasal drops: a new formulation.
    Denyer S
    Allergy; 1999; 54 Suppl 53():17-20. PubMed ID: 10442546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and evaluation of in situ gelling system of dimenhydrinate for nasal administration.
    Belgamwar VS; Chauk DS; Mahajan HS; Jain SA; Gattani SG; Surana SJ
    Pharm Dev Technol; 2009; 14(3):240-8. PubMed ID: 19235555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality by design-based optimization of in situ ionic-sensitive gels of amoxicillin-loaded bovine serum albumin nanoparticles for enhanced local nasal delivery.
    Mardikasari SA; Katona G; Budai-Szűcs M; Sipos B; Orosz L; Burián K; Rovó L; Csóka I
    Int J Pharm; 2023 Oct; 645():123435. PubMed ID: 37741560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal drug delivery: Design of a novel mucoadhesive and in situ gelling polymer.
    Menzel C; Jelkmann M; Laffleur F; Bernkop-Schnürch A
    Int J Pharm; 2017 Jan; 517(1-2):196-202. PubMed ID: 27890621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimuli-responsive In situ gelling system for nose-to-brain drug delivery.
    Agrawal M; Saraf S; Saraf S; Dubey SK; Puri A; Gupta U; Kesharwani P; Ravichandiran V; Kumar P; Naidu VGM; Murty US; Ajazuddin ; Alexander A
    J Control Release; 2020 Nov; 327():235-265. PubMed ID: 32739524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and evaluation of in situ gelling systems for intranasal administration of gastrodin.
    Cai Z; Song X; Sun F; Yang Z; Hou S; Liu Z
    AAPS PharmSciTech; 2011 Dec; 12(4):1102-9. PubMed ID: 21879392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucoadhesive in situ nasal gelling drug delivery systems for modulated drug delivery.
    Singh RM; Kumar A; Pathak K
    Expert Opin Drug Deliv; 2013 Jan; 10(1):115-30. PubMed ID: 23199072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine.
    Chen Y; Liu Y; Xie J; Zheng Q; Yue P; Chen L; Hu P; Yang M
    Int J Nanomedicine; 2020; 15():10435-10451. PubMed ID: 33380794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nose-to-Brain Delivery of Diazepam from an Intranasal Aqua-Triggered In-Situ (ATIS) Gelling Microemulsion: Monitoring Brain Uptake by Microdialysis.
    Bachhav SS; Dighe V; Mali N; Gogtay NJ; Thatte UM; Devarajan PV
    Eur J Drug Metab Pharmacokinet; 2020 Dec; 45(6):785-799. PubMed ID: 32813265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.